Alnylam CEO John Maraganore: It's hard to justify drug price increases

1:18 PM ET Thu, 30 Nov 2017

CNBC's Meg Tirrell speaks with John Maraganore, Alnylam CEO, about pricing for his company's new drug and his thoughts on Amazon's potential break into the biopharma industry.